畜牧兽医学报 ›› 2025, Vol. 56 ›› Issue (10): 5239-5250.doi: 10.11843/j.issn.0366-6964.2025.10.043

• 临床兽医 • 上一篇    下一篇

利用牛子宫内膜上皮细胞和小鼠子宫内膜炎模型评价胎盘组织源脂质体载药复合物的效果

周瑾1(), 庄玉洁1, 张雅琳1, 谢小雨1, 孙明珠1, 张雪梅2, 王小龙2, 张志平1,*(), 张君涛1,*()   

  1. 1. 河南农业大学动物医学院, 郑州 450046
    2. 河南省银丰生物工程技术有限公司, 郑州 450001
  • 收稿日期:2024-10-30 出版日期:2025-10-23 发布日期:2025-11-01
  • 通讯作者: 张志平,张君涛 E-mail:1055542766@qq.com;zhipingzhang@henau.edu.cn;juntaozhang@henau.edu.cn
  • 作者简介:周瑾(1999-),男,河南唐河县人,硕士,主要从事药物的载体脂质体研究,E-mail: 1055542766@qq.com

Antibacterial Test of Placental Tissue-derived Liposome Drug Complex in Endometritis Model

ZHOU Jin1(), ZHUANG Yujie1, ZHANG Yalin1, XIE Xiaoyu1, SUN Mingzhu1, ZHANG Xuemei2, WANG Xiaolong2, ZHANG Zhiping1,*(), ZHANG Juntao1,*()   

  1. 1. College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China
    2. Henan Yinfeng Bioengineering Technology Co., Ltd., Zhengzhou 450001, China
  • Received:2024-10-30 Online:2025-10-23 Published:2025-11-01
  • Contact: ZHANG Zhiping, ZHANG Juntao E-mail:1055542766@qq.com;zhipingzhang@henau.edu.cn;juntaozhang@henau.edu.cn

摘要:

本研究旨在评估胎盘来源的磷脂作为抗菌药物载体的可行性,并探索用于治疗子宫内膜炎。用大肠杆菌(E. coli)诱导牛子宫内膜上皮细胞构建体外炎症模型和小鼠子宫内膜炎在体模型,评价庆大霉素-胎盘脂质体复合物(L-GEN)治疗效果。结果显示:用薄膜分散法制备庆大霉素脂质体(L-GEN);L-GEN混悬液呈乳白色,泛蓝光,且流动性较好;纳米粒度电位仪测得L-GEN粒径为293.7 nm±2.4 nm,分散系数为0.21±0.02。测试发现30 d内L-GEN粒径无显著变化,表明脂质体较稳定。转录组测序分析显示,L-GEN组相比于对照组,对牛子宫内膜细胞影响更小,经KEGG通路富集发现,主要富集在PPAR信号通路影响细胞脂质代谢,降低细胞损伤和炎性,抗菌活性增强。在体试验发现,L-GEN可通过缓解E. coli灌注后小鼠子宫组织的充血肿胀以及炎性细胞浸润,炎性相关基因IL-2、IL-6、IL-1β、TNF-α、TLR2表达水平下降(P≤0.05),缓解小鼠子宫内膜损伤和炎症反应。经子宫内膜炎细胞模型和小鼠子宫内膜炎在体模型验证,发现胎盘源脂质体载药复合体可有效缓减子宫内膜炎性反应,增强治疗效果,为后续使用组织源脂质体运载抗生素治疗子宫内膜炎提供参考。

关键词: 庆大霉素脂质复合物, 大肠杆菌, 子宫内膜细胞, 子宫内膜炎

Abstract:

This study aimed to evaluate the feasibility of placenta-derived phospholipids as carriers for antibacterial drugs and explore their application in the treatment of endometritis. An in vitroinflammatory model of bovine endometrial epithelial cells and an in vivomodel of endometritis in mice were established using Escherichia coli (E. coli), and the therapeutic effect of gentamicin-placenta lipid complex (L-GEN) was evaluated. Results were as follows: Gentamicin liposomes (L-GEN) were prepared by the film dispersion method; the L-GEN suspension was milky white with a bluish tinge and good fluidity. The particle size of L-GEN was measured by a nanoparticle size and zeta potential analyzer to be 293.7 nm±2.4 nm, with a polydispersity index of 0.21±0.02. No significant change in the particle size of L-GEN was observed within 30 days, indicating the stability of the liposomes. Transcriptome sequencing analysis showed that L-GEN had a smaller impact on bovine endometrial cells compared to the control group. KEGG pathway enrichment analysis revealed that L-GEN mainly enriched in the PPAR signaling pathway, affecting cellular lipid metabolism, reducing cell damage and inflammation, and enhancing antibacterial activity. In vivo experiments found that L-GEN could alleviate the congestion and swelling of the mouse uterus tissue and inflammatory cell infiltration after E. coli perfusion, and the expression levels of inflammatory-related genes IL-2, IL-6, IL-1β, TNF-α, and TLR2 decreased (P≤ 0.05), thereby alleviating endometrial damage and inflammatory response in mice. Through the endometritis cell model and the in vivomodel of endometritis in mice, it was found that the placenta-derived lipid drug delivery complex can effectively alleviate endometrial inflammatory responses and enhance therapeutic effects, providing a reference for the subsequent use of tissue-derived liposomes to carry antibiotics for the treatment of endometritis.

Key words: gentamicin lipid complex, Escherichia coli, endometrial cells, endometritis

中图分类号: